Idera Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update
October 29, 2020 16:36 ET
|
Idera Pharmaceuticals, Inc.
EXTON, Pa., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera” or the “Company”) (Nasdaq: IDRA) today reported its financial and operational results for the third quarter ended...
Idera Pharmaceuticals Announces New U.S. Patent Coverage for Tilsotolimod Through September 2037
September 28, 2020 08:45 ET
|
Idera Pharmaceuticals, Inc.
EXTON, Pa., Sept. 28, 2020 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,772,907 (the ‘907...
Bombardier étend le soutien mondial à la clientèle par des capacités accrues de réparations structurelles
July 27, 2020 10:19 ET
|
Bombardier Avions d’affaires
Les capacités accrues procurent aux clients un soutien inégalé et plus de raison de ramener leurs avions dans les centres de services de Bombardier Le Centre de réponse à la clientèle (CRC) de...
Bombardier Expands Worldwide Customer Support with Enhanced Structural Repair Capabilities
July 27, 2020 10:19 ET
|
Bombardier Business Aircraft
Extended capabilities provide customers with unparalleled support and more reasons to bring their jets home to Bombardier Bombardier’s Customer Response Center (CRC) remains the single point of...
Never Too Young Survey Report Shows Young-Onset Colorectal Cancer Continues to be Overlooked in Exam Rooms
June 04, 2020 11:27 ET
|
Colorectal Cancer Alliance
Washington, D.C., June 04, 2020 (GLOBE NEWSWIRE) -- Today, during Young Survivors Week, national leading non-profit Colorectal Cancer Alliance released findings from its latest survey of young-onset...
Updated: Expert Stakeholder Panel Focuses on Colorectal Cancer Screening in the COVID-19 Era
May 15, 2020 15:27 ET
|
Colorectal Cancer Alliance
Washington, D.C., May 15, 2020 (GLOBE NEWSWIRE) -- COVID-19 has produced far-reaching and significant health impacts, including a drastic reduction in all cancer screenings. In response, national...
Idera Pharmaceuticals Announces Tilsotolimod Program Updates to be Presented at AACR Virtual Annual Meeting 2020
April 23, 2020 07:30 ET
|
Idera Pharmaceuticals, Inc.
EXTON, Pa., April 23, 2020 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera”) (Nasdaq: IDRA) today announced that updates on ILLUMINATE-206 and ILLUMINATE-101, two studies investigating...
Colorectal Cancer Alliance Opens Young-Onset Colorectal Cancer Survey
June 20, 2019 16:23 ET
|
Colorectal Cancer Alliance
Washington, D.C., June 20, 2019 (GLOBE NEWSWIRE) -- National nonprofit Colorectal Cancer Alliance is calling on allies to participate in its fourth annual survey of young-onset colorectal cancer...
National Nonprofit the Colorectal Cancer Alliance Provides Funding to Help Fill Urgent Colon and Rectal Cancer Research Needs
January 23, 2019 16:24 ET
|
Colorectal Cancer Alliance
Washington, D.C., Jan. 23, 2019 (GLOBE NEWSWIRE) -- National nonprofit Colorectal Cancer Alliance is providing a total of $625,000 in grants to four researchers, including one advancing personalized...
Report: Most Young-Onset Colorectal Cancer Patients Diagnosed at Advanced Stages
December 19, 2018 16:21 ET
|
Colorectal Cancer Alliance
Washington, D.C., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Nearly three-quarters of young-onset colorectal cancer patients are diagnosed with an advanced stage of the disease, a significantly higher...